Rheb fills a GAP between TSC and TOR

被引:391
作者
Manning, BD [1 ]
Cantley, LC [1 ]
机构
[1] Harvard Univ, Sch Med, Dept Cell Biol,Harvard Inst Med, Div Signal Transduct,Beth Israel Deaconess Med Ct, Boston, MA 02115 USA
关键词
D O I
10.1016/j.tibs.2003.09.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
There has been much interest in determining the molecular and cellular functions of hamartin and tuberin, which are encoded by the genes TSC1 and TSC2 that are mutated in the tuberous sclerosis complex disease. Recently, several laboratories have independently reported a major breakthrough in this field. Together, these genetic, biochemical and cell-biological studies have demonstrated that the tuberin-hamartin complex inhibits target of rapamycin (TOR) signaling by acting as a GTPase-activating protein for the Ras-related small G protein Rheb.
引用
收藏
页码:573 / 576
页数:4
相关论文
共 25 条
  • [1] Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner
    Castro, AF
    Rebhun, JF
    Clark, GJ
    Quilliam, LA
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (35) : 32493 - 32496
  • [2] Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling
    Gao, XS
    Zhang, Y
    Arrazola, P
    Hino, O
    Kobayashi, T
    Yeung, RS
    Ru, BG
    Pan, DJ
    [J]. NATURE CELL BIOLOGY, 2002, 4 (09) : 699 - 704
  • [3] TSC1 and TSC2 tumor suppressors antagonize insulin signaling in cell growth
    Gao, XS
    Pan, DJ
    [J]. GENES & DEVELOPMENT, 2001, 15 (11) : 1383 - 1392
  • [4] Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2
    Garami, A
    Zwartkruis, FJT
    Nobukuni, T
    Joaquin, M
    Roccio, M
    Stocker, H
    Kozma, SC
    Hafen, E
    Bos, JL
    Thomas, G
    [J]. MOLECULAR CELL, 2003, 11 (06) : 1457 - 1466
  • [5] Gomez M., 1999, Tuberous sclerosis, V3
  • [6] Rheb is in a high activation state and inhibits B-Raf kinase in mammalian cells
    Im, E
    von Lintig, FC
    Chen, J
    Zhuang, SH
    Qui, WS
    Chowdhury, S
    Worley, PF
    Boss, GR
    Pilz, RB
    [J]. ONCOGENE, 2002, 21 (41) : 6356 - 6365
  • [7] TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling
    Inoki, K
    Li, Y
    Zhu, TQ
    Wu, J
    Guan, KL
    [J]. NATURE CELL BIOLOGY, 2002, 4 (09) : 648 - 657
  • [8] Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling
    Inoki, K
    Li, Y
    Xu, T
    Guan, KL
    [J]. GENES & DEVELOPMENT, 2003, 17 (15) : 1829 - 1834
  • [9] Tuberous sclerosis complex tumor suppressor-mediated S6 kinase inhibition by phosphatidylinositide-3-OH kinase is mTOR independent
    Jaeschke, A
    Hartkamp, J
    Saitoh, M
    Roworth, W
    Nobukuni, T
    Hodges, A
    Sampson, J
    Thomas, G
    Lamb, R
    [J]. JOURNAL OF CELL BIOLOGY, 2002, 159 (02) : 217 - 224
  • [10] Kenerson HL, 2002, CANCER RES, V62, P5645